Taxes on Sugar-Sweetened Beverages to Reduce Overweight and Obesity in Middle-Income Countries: A Systematic Review.
BACKGROUND
The consumption of sugar-sweetened beverages (SSBs), which can lead to weight gain, is rising in middle-income countries (MICs). Taxing SSBs may help address this challenge. Systematic reviews focused on high-income countries indicate that taxing SSBs may reduce SSB consumption. Responsiveness to price changes may differ in MICs, where governments are considering the tax. To help inform their policy decisions, this review compiles evidence from MICs, assessing post-tax price increases (objective 1), changes in demand for SSBs and other products, overall and by socio-economic groups (objective 2), and effects on overweight and obesity prevalence (objective 3).


RESULTS
We conducted a systematic review on the effectiveness of SSB taxation in MICs (1990-2016) and identified nine studies from Brazil, Ecuador, India, Mexico, Peru, and South Africa. Estimates for own-price elasticity ranged from -0.6 to -1.2, and decreases in SSB consumption ranged from 5 to 39 kilojoules per person per day given a 10% increase in SSB prices. The review found that milk is a likely substitute, and foods prepared away from home, snacks, and candy are likely complements to SSBs. A quasi-experimental study and two modeling studies also found a negative relationship between SSB prices and obesity outcomes after accounting for substitution effects. Estimates are consistent despite variation in baseline obesity prevalence and per person per day consumption of SSBs across countries studied.


CONCLUSIONS
The review indicates that taxing SSBs will increase the prices of SSBs, especially sugary soda, in markets with few producers. Taxing SSBs will also reduce net energy intake by enough to prevent further growth in obesity prevalence, but not to reduce population weight permanently. Additional research using better survey data and stronger study designs is needed to ascertain the long-term effectiveness of an SSB tax on obesity prevalence in MICs.
International Health Division, Abt Associates, Bethesda, Maryland, United States of America.
Sharon S
SS
Nakhimovsky
Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
Andrea B
AB
Feigl
International Health Division, Abt Associates, Bethesda, Maryland, United States of America.
Carlos
C
Avila
International Health Division, Abt Associates, Bethesda, Maryland, United States of America.
Gael
G
O'Sullivan
International Health Division, Abt Associates, Bethesda, Maryland, United States of America.
Elizabeth
E
Macgregor-Skinner
Office of Reputational Capital, Abt Associates, Cambridge, Massachusetts, United States of America.
Mark
M
Spranca
Health Policy. 2012 Sep;107(1):83-90
22727243
PLoS One. 2016 Mar 30;11(3):e0152260
27028608
Circulation. 2015 Aug 25;132(8):639-66
26124185
Nature. 2012 Feb 01;482(7383):27-9
22297952
Econ Hum Biol. 2015 Dec;19:129-37
26386463
BMJ. 2016 Jan 06;352:h6704
26738745
Curr Obes Rep. 2014 Dec;3(4):432-9
26626920
J Hum Nutr Diet. 2015 Feb;28 Suppl 2:70-9
24548259
Int J Obes (Lond). 2011 Jul;35(7):1001-9
21079620
Pediatrics. 2013 May;131(5):919-27
23629613
Obes Rev. 2013 Aug;14(8):606-19
23763695
Am J Public Health. 2012 Jan;102(1):178-83
22095333
Obesity (Silver Spring). 2008 Aug;16(8):1843-8
18535543
Nutr Rev. 2014 Sep;72(9):551-65
25091552
PLoS Med. 2009 Jul 21;6(7):e1000100
19621070
Public Health Nutr. 2013 Jul;16(7):1291-5
23174136
Nutr Rev. 2004 Jul;62(7 Pt 2):S163-8
15387484
Nutr Rev. 2012 Jan;70(1):3-21
22221213
Health Aff (Millwood). 2015 Sep;34(9):1480-8
26355049
Food Nutr Bull. 2011 Sep;32(3):227-43
22073797
Am J Public Health. 2015 Nov;105(11):2194-201
26444622
PLoS Med. 2012;9(12):e1001353
23239943
N Engl J Med. 2009 Oct 15;361(16):1599-605
19759377
BMJ. 2012 Mar 02;344:e586
22389336
Lancet. 2011 Aug 27;378(9793):826-37
21872751
BMJ. 2013 Jun 17;346:f3703
23775799
PLoS One. 2015 Dec 14;10(12):e0144408
26675166
PLoS Med. 2014 Jan;11(1):e1001582
24409102
BMC Public Health. 2013 Nov 13;13:1072
24225016
J Nutr. 2008 Dec;138(12 ):2454-61
19022972
Circulation. 2010 Mar 23;121(11):1356-64
20308626
Clinicoecon Outcomes Res. 2013 Oct 22;5:519-43
24187507
Electrophoresis. 2013 May;34(9-10):1343-51
23483553
PLoS One. 2014 Aug 19;9(8):e105287
25136987
Lancet Diabetes Endocrinol. 2016 Feb;4(2):174-86
26654575
Obes Rev. 2013 Feb;14(2):110-28
23174017
PLoS One. 2015 Nov 17;10(11):e0143050
26575644